In a study trial, pharmaceutical giant Eli Lilly's weight-loss drug Zepbound ... As the demand for effective obesity treatments grows, this war of weight-loss drugs between Zepbound and Wegovy ...

Danish biopharma powerhouse Novo Nordisk is taking another bold move in the obesity market, this time licensing a new type of GLP-1 that could directly compete with a candidate in Eli Lilly’s ...

Amid the war on obesity, a clear winner has emerged in a battle between two weight-loss injectables. Zepbound (tirzepatide), manufactured by Fortune 500 firm Eli Lilly & Co., bested competitor ...

PLEASANT PRAIRIE, Wis. — Eli Lilly and Company won final approval for site and operation plans for additions to its Pleasant Prairie facility. In December, the company announced an expansion in ...

Eli Lilly and Novo Nordisk have scored big wins from the FDA in recent months, as the agency cracks down on copycat versions of their GLP-1 blockbusters. Now, as the battle with compound GLP-1s ...